Trials / Unknown
UnknownNCT02238587
The Effect of Ganoderma on Patients With Head-and-neck Cancer
The Effect of Gandoerma Spores Powder Capsules on the Post-treatment Life Quality and Immune Modulation of the Patients With Head-and-neck Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Chang Bing Show Chwan Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To study the effect of Ganoderma Spores Powder Capsules on the life quality and immunity status of the patients with head-and-neck cancer after complete treatment (including surgery and / or radiotherapy and/or chemotherapy)
Detailed description
Ganoderma is known to modulate immunity and improve health. However, the mechanism is not clear. We hypothesize that patients who have completed standard treatment with/without radiotherapy might require biological modifier such as Ganoderma to improve life quality and immunity status. A total of 100 patients are randomized to study and control groups. In study group, Ganoderma Spores Powder Capsules are given to the patients for 6 weeks, In control group, only placebos are given during the same period. Then the patients in study and control groups are switched, Ganoderma Spores Powder Capsules and placebos are given for 6 weeks. The data pertaining to their Life quality are collected using Quality of Life Questionnaire after the first 6 weeks and the second 6 weeks. The immunity status is also studied at the same time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Control group | In control group, only placebos are given for 6 weeks. The patients who are in control groups are switched to receive Ganoderma Spores Powder Capsules for 6 weeks. |
| DIETARY_SUPPLEMENT | Ganoderma Spores Powder Capsules | In experimental group, Ganoderma Spores Powder Capsules for 12 weeks. |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2014-09-12
- Last updated
- 2014-09-12
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02238587. Inclusion in this directory is not an endorsement.